Farrands P A, Perkins A C, Pimm M V, Embleton M J, Hardy J D, Baldwin R W, Hardcastle J D
Lancet. 1982 Aug 21;2(8295):397-400. doi: 10.1016/s0140-6736(82)90437-8.
In 10 out of 11 patients with colorectal cancer radiolabelled antitumour monoclonal antibody (791T/36) was localised to the tumour. The mean tumour to non-tumour uptake ratio of antibody demonstrated by imaging with a gamma camera was 4.4/1 after subtraction of background radioactivity. The antibody did not localise in one patient who had received radiotherapy to his tumour two weeks previously. In 5 patients with primary neoplasms localisation of the antibody was confirmed by further imaging of the resected specimens and in-vitro radioactivity counting of the tumour and comparison with the activity in adjacent normal colon.
在11例结直肠癌患者中,有10例的放射性标记抗肿瘤单克隆抗体(791T/36)定位于肿瘤部位。用γ相机成像显示,扣除本底放射性后,抗体的肿瘤与非肿瘤摄取平均比值为4.4/1。有1例患者两周前曾接受肿瘤放疗,抗体未在其体内定位。在5例原发性肿瘤患者中,通过对切除标本的进一步成像、肿瘤的体外放射性计数以及与相邻正常结肠活性的比较,证实了抗体的定位。